
Research use only — not for human or veterinary use.
RESEARCH USE ONLYNOT FOR HUMAN OR VETERINARY USE
Research Blends

80 mg
$199per vial · 80 mg lyophilised powder
KL04260380CRESEARCH USE ONLYNOT FOR HUMAN OR VETERINARY USE
RESEARCH USE ONLY. This material is supplied strictly for in-vitro laboratory research by qualified professionals. It is not a drug, food, cosmetic, or medical device. It is not for human or veterinary use, and introduction into the body of a human or animal by any route is prohibited. Elitist Peptides supplies no dosing, reconstitution, administration, or research-protocol guidance, and declines all requests for it.
EP-B80 is a house research blend of GHK-Cu, BPC-157, TB-500 and KPV totalling 80 mg per vial. The lot certificate reports all four components individually by identity and mass.
| Compound | EP-B80 GHK-Cu / BPC-157 / TB-500 / KPV Blend |
|---|---|
| Fill mass per vial | 80 mg |
| Research category | Research Blends |
| CAS number | Not available.Not applicable to a multi-component preparation. |
| Sequence | Not available.Reported per component by identity and mass on the lot certificate. |
| Molecular formula and mass | Not available.Not applicable to a multi-component preparation. Each component is reported separately by identity and mass on the lot certificate. |
| Physical form | Lyophilised powder |
| Storage | Cold storage on receipt; keep sealed, dry and out of light |
| Analytical record | Per-lot certificate of analysisThe methods actually run, and the tests that were not run, are named on the certificate for the lot supplied. |
No medical advice. Nothing on this website is medical, veterinary, pharmaceutical, or professional advice, and no content here describes a use, benefit, or outcome in a human or an animal. Elitist Peptides does not supply dosing, reconstitution, administration, or research-protocol guidance. If you contact us for that information you will receive a written refusal and no guidance.
KL04260380CMeasured net fill by component — lot KL04260380C
| Component | Measured mass |
|---|---|
| GHK-Cu (GHK content) | 50.86 mg |
| BPC-157 | 12.12 mg |
| TB-500 (TB4) | 11.63 mg |
| KPV | 10.98 mg |
The laboratory determined identity and amount for this lot. It did not determine a purity percentage, so none is shown.
Tests not performed on this lotSterility · Residual TFA
About this certificate. Certificates of analysis are lot-specific. A certificate reports only the tests actually performed on the lot identified on it, by the laboratory named on it, on the date shown — typically identity and purity by HPLC/MS and net fill mass. It is not a statement of sterility, endotoxin content, or fitness for any purpose, and a result for one lot does not describe any other lot. Tests not listed on a certificate were not performed.
Everything issued against this lot — the request line, separate reports, verification key status and any earlier certificates — is on its verification page.
Search every published certificate by lot code in the certificate index.
Handling and storage. Lyophilised material ships at ambient temperature in insulated packaging and must be transferred to cold storage promptly on receipt by trained laboratory personnel. Keep sealed, dry, and protected from light. This is a storage instruction for the material as supplied to a laboratory. It is not preparation, reconstitution, or use guidance.
The lot code printed on the carton is the only identifier that ties a vial to its certificate of analysis. Each lot code resolves to a permanent, public certificate page — no account, no login and no blur. Where a certificate is later superseded by a re-test, the earlier version is retained and stays reachable.
We do not provide reconstitution volumes, dosing, administration routes, schedules, cycles, or research protocols of any kind, for any material, to any customer. Requests for that information receive a written refusal and no guidance. Any communication indicating intended use in or on a human or an animal will result in refusal of sale, cancellation of open orders, and closure of the account.